Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-01 · accession 0001415889-25-019334 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-03 | 2025-07-01 | KNSA | Levy Richard S | Dir | M - OptEx | — | +1,101 | 18.5K | +6% | — |
| D | 2025-07-03 | 2025-07-01 | KNSA | Levy Richard S | Dir | A - Grant | $0.00 | +1,101 | 1,101 | New | $0 |
| D | 2025-07-03 | 2025-07-01 | KNSA | Levy Richard S | Dir | M - OptEx | $0.00 | -1,101 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-07-01 | M | A | 1,101 | — | 18,474 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 2 | Derivative | Restricted Share Units | 2025-07-01 | A | A | 1,101 | $0.00 | 1,101 | D | — · — to — | 1,101 Class A Ordinary Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vested immediately upon grant on July 1, 2025; there was no expiration date for the RSUs. |
| 3 | Derivative | Restricted Share Units | 2025-07-01 | M | D | 1,101 | $0.00 | 0 | D | — · — to — | 1,101 Class A Ordinary Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vested immediately upon grant on July 1, 2025; there was no expiration date for the RSUs. |